EGFR and non-small cell lung carcinoma: The most prevalent driver mutations in non-small cell lung cancer (NSCLC) are associated with alterations in the epidermal growth factor receptor (EGFR) gene, which encodes a receptor tyrosine kinase that plays a critical role in regulating cellular growth and division [144,145,146].